Precision Neuroscience Raises $250 Million at $1 Billion-Plus Valuation
Updated
Updated · The New York Times · Sep 24
Precision Neuroscience Raises $250 Million at $1 Billion-Plus Valuation
1 articles · Updated · The New York Times · Sep 24
Summary
$250 million in new financing values Precision Neuroscience at just over $1 billion, marking a major funding win for the New York brain-computer interface startup.
Bill Ackman is a key backer, with $42.5 million coming from Pershing Square and the Ackman Oxman Institute, the brain research center he recently founded with Neri Oxman.
Founded in 2021, Precision is developing a less invasive brain-computer interface than Neuralink's approach, using sensors to read neural signals and help patients communicate or control devices.
The raise underscores a broader investor rush into brain-computer interfaces, as executives, venture capital firms and sovereign wealth investors bet the technology can aid people with severe neurological injuries or disease.
Will Precision's surface-level brain implant dethrone Neuralink, or will rapid advances in completely non-invasive headsets render both obsolete?
As billionaires pour fortunes into brain-reading tech, who will ultimately own and protect your most private neural data from hackers?
Could a billionaire's personal family tragedy be the catalyst that finally brings safe, FDA-approved mind-control technology into mainstream hospitals?